Target Price | GBP0.84 |
Price | GBP0.77 |
Potential |
9.80%
register free of charge
|
Number of Estimates | 8 |
8 Analysts have issued a price target Dr Martens 2026 .
The average Dr Martens target price is GBP0.84.
This is
9.80%
register free of charge
GBP1.14
49.02%
register free of charge
GBP0.66
13.73%
register free of charge
|
|
A rating was issued by 8 analysts: 3 Analysts recommend Dr Martens to buy, 5 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Dr Martens stock has an average upside potential 2026 of
9.80%
register free of charge
|
Mar '25 |
2026 Estimates |
|
---|---|---|
Revenue Million GBP | 787.60 | 811.50 |
10.20% | 3.03% | |
EBITDA Margin | 18.08% | 19.84% |
20.19% | 9.73% | |
Net Margin | 0.57% | 5.18% |
92.76% | 806.62% |
7 Analysts have issued a sales forecast Dr Martens 2026 . The average Dr Martens sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Dr Martens EBITDA forecast 2026. The average Dr Martens EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Dr Martens Analysts have issued a net profit forecast 2026. The average Dr Martens net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Mar '25 |
2026 Estimates |
|
---|---|---|
Earnings Per Share GBP | 0.00 | 0.04 |
100.00% | ||
P/E | 17.57 | |
EV/Sales | 1.25 |
Analyst | Rating | Action | Date |
---|---|---|---|
RBC Capital Markets |
Locked
➜
Locked
|
Locked | May 19 2025 |
Analyst Rating | Date |
---|---|
Locked
RBC Capital Markets:
Locked
➜
Locked
|
May 19 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.